Minimal clinically important difference for acupuncture for patients with chronic spontaneous urticaria: secondary analysis from a multicentre randomised controlled trial in China
Open Access
Abstract
Objectives To evaluate the minimal clinically important difference (MCID) value for acupuncture treatment in chronic spontaneous urticaria (CSU), providing guidance for its application in CSU management. Design Secondary analysis of data from a multicentre randomised controlled trial. Setting Three tertiary hospitals across three cities in China. Participants 103 CSU patients (78.7% female) with an average age of 39.97 years. Interventions Participants received acupuncture treatment for 4 weeks in the original study. Outcome measures MCID and minimal detectable change (MDC) for the Urticaria Activity Score over 7 days (UAS7) in acupuncture treatment of CSU. Convergent validity assessed by intraclass correlation coefficient (ICC). Responsiveness evaluated through Spearman correlation between UAS7 improvements and anchor tools (physician’s and patient’s assessments). MDC calculated using SE of measurement of changes in UAS7 scores. MCID estimated using distribution-based and anchor-based methods. Results The ICC for UAS7 was 0.86. Improvements in UAS7 scores were significantly correlated with patient (r=0.44, pConclusions This study provides the first MCID value for acupuncture treatment in CSU. These findings contribute to the understanding of acupuncture’s effects in treating CSU and may inform future research and clinical practice in the management of this condition. Trial registration number ChiCTR1900022994.Keywords
Funding Information
- Natural Science Foundation of Sichuan Provincial Department of Science and Technology (2024NSFSC0728)
- China Postdoctoral Science Foundation (2021MD693787, 2022MD723719)
- National Natural Science Foundation of China (82105026, 82205283, 82305410)
This publication has 23 references indexed in Scilit:
- Measurement Error, Minimal Detectable Change, and Minimal Clinically Important Difference of the Short Form-36 Health Survey, Hospital Anxiety and Depression Scale, and Pain Numeric Rating Scale in Patients With Chronic PainThe Journal of Pain, 2024
- An Assessment of Current Clinician-Reported and Patient-Reported Outcome Measures for Alopecia Areata: A Scoping ReviewJournal of Investigative Dermatology, 2023
- Chronic spontaneous urticaria guidelines: What is new?Journal of Allergy and Clinical Immunology, 2022
- The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticariaAllergy, 2021
- Chronic Urticaria: Advances in Understanding of the Disease and Clinical ManagementClinical Reviews in Allergy & Immunology, 2021
- Clinically significant differences in patient-reported outcomes evaluations in chronic spontaneous urticariaCurrent Opinion in Allergy and Clinical Immunology, 2020
- Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta‐analysisAllergy, 2019
- The Urticaria Activity Score—Validity, Reliability, and ResponsivenessThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSUAllergy, 2017
- Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticariaAnnals of Allergy, Asthma & Immunology, 2012